Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 103305

In scope icon M 11 E
QID 103305 (Type "103305" in App Search)
A 62-year-old woman with a history of hypertension and type II diabetes presents to her primary care physician with a complaint of constipation that has progressively worsened over the past 4 months. She denies any pain with defecation, blood in her stool, or changes in stool color. The patient reports having undergone a colonoscopy 3 months ago, which did not reveal any abnormalities. Her vital signs at this visit are within normal limits. Physical examination, including a rectal exam, does not reveal any abnormalities. Given the patient’s presentation and findings, which of the following is the most appropriate initial pharmacological intervention for this patient?

Bisacodyl

0%

0/7

Docusate

0%

0/7

Lactulose glycol

86%

6/7

Polyethylene glycol

0%

0/7

Psyllium

14%

1/7

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

The correct answer is Psyllium. This patient’s symptoms are suggestive of functional constipation, for which the first-line treatment is lifestyle modifications such as increased fluid and fiber intake. Psyllium is a bulk-forming laxative that can help increase dietary fiber.

Constipation is common in the elderly and children and can present with abdominal pain and trouble having bowel movements. When severe, it can lead to nausea, vomiting, and delirium (in the elderly). The best initial step in management in the treatment of constipation is to recommend the patient increase their fiber and water intake (with supplements such as psyllium being frequently used) as well as to engage in exercise. In patients who do not respond to bulk-forming laxatives and dietary changes, additional classes of medications can be tried, including osmotic laxatives, stimulant laxatives, or emollient laxatives. Osmotic laxatives increase the amount of water in the colon and small intestine, thereby improving the pliability and passage of the stool (examples include milk of magnesia, magnesium citrate, and polyethylene glycol). Stimulant laxatives increase the motor activity of the bowel walls to expedite stool passage (examples include senna and bisacodyl). Emollient laxatives add moisture to the stool by coating the inside of the colon with oil, thereby decreasing water reabsorption (examples include mineral oil and docusate).

The study by Chey et al. conducted a comparative effectiveness trial evaluating the impact of kiwifruit, psyllium, and prunes on patients with chronic constipation (CC) in the United States. The study found that all three treatments significantly increased the weekly rate of complete spontaneous bowel movements (CSBMs). Stool consistency improved significantly with kiwifruit and prunes, while straining improved with all three treatments. Interestingly, patients in the kiwifruit group reported significant improvement in bloating scores. Adverse events were most common with psyllium and least common with kiwifruit. At the end of the treatment, fewer patients were dissatisfied with kiwifruit compared to prunes or psyllium. The study concluded that kiwifruit, prunes, and psyllium all improve constipation symptoms in patients with CC, with kiwifruit associated with the lowest rate of adverse events and dissatisfaction with therapy.

Incorrect Answers:

Answer 1: Bisacodyl is a stimulant laxative that increases intestinal motility. It is typically used for short-term relief of acute constipation or for bowel preparation before medical procedures but is not the first-line treatment for chronic functional constipation.

Answer 2: Docusate is an emollient or stool softener that makes the stool easier to pass. It is often used for preventing constipation in patients taking opioid medications but is not the first-line treatment for functional constipation.

Answer 3: Lactulose is an osmotic laxative that draws water into the intestines to soften the stool and stimulate bowel movements. It is often used for treating constipation in patients with liver disease but is not the first-line treatment for functional constipation.

Answer 4: Polyethylene glycol is an osmotic laxative that can be used for treating chronic constipation if lifestyle modifications and bulk-forming laxatives are insufficient.

Bullet Summary: The first-line treatment for functional constipation includes lifestyle modifications such as increased fluid and fiber intake (with psyllium being a common agent for increasing fiber intake).

REFERENCES (1)
Authors
Rating
Please Rate Question Quality

5.0

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(1)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options